Skip to main content
Main menu
About
Our Mission
Donors
Board of Directors
Advisory Boards
Staff
Careers
Who we are
FAQ
Annual Report
Why New TB Drugs?
Global Pandemic
Inadequate Treatment
Antimicrobial Resistance
Maternal and Child Health
Cycle of Poverty
R&D
Scientific Vision
Pipeline
Discovery
Engaging Communities
Access
Our Commitment
Access in TB Market
Child-friendly medicines
Pretomanid and BPaL
Pathways to Access BPaL
News
Latest News
Publications
Voices of TB
Research Papers
Making an Impact
Donate
Search form
Search
News Archive
July 10, 2005
G8 Recognizes Non-Profit R&D Model for Neglected Diseases
July 4, 2005
TB Alliance Appoints Nina Schwalbe as Director of Policy
June 16, 2005
Drug Companies Appeal For G8 Backing to Fight Diseases
June 15, 2005
TB drug trials begin in Nebraska
June 13, 2005
Nonprofit to test novel tuberculosis drug worldwide
June 13, 2005
First Tuberculosis Drug Developed by a Non-profit Begins Clinical Trials
June 7, 2005
TB Drug Research Picks Up the Pace
May 11, 2005
Event Spotlight: Gordon Research Conference on TB Drug Development
May 11, 2005
Developing Countries Innovating for Global Health
May 11, 2005
The British Department for International Development (DFID) Outlines Role Pharmaceutical Industry Can Play in Access to Essential Medicines
Pages
«
‹
…
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
…
›
»